Boston Scientific Net Income 2006-2018 | BSX

Boston Scientific annual/quarterly net income history and growth rate from 2006 to 2018. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Boston Scientific net income for the quarter ending December 31, 2018 was $0.386B, a 162.76% decline year-over-year.
  • Boston Scientific net income for the twelve months ending December 31, 2018 was $1.671B, a 1506.73% increase year-over-year.
  • Boston Scientific annual net income for 2018 was $1.671B, a 1506.73% increase from 2017.
  • Boston Scientific annual net income for 2017 was $0.104B, a 70.03% decline from 2016.
  • Boston Scientific annual net income for 2016 was $0.347B, a 245.19% decline from 2015.
Boston Scientific Annual Net Income
(Millions of US $)
2018 $1,671
2017 $104
2016 $347
2015 $-239
2014 $-119
2013 $-121
2012 $-4,068
2011 $441
2010 $-1,065
2009 $-1,025
2008 $-2,036
2007 $-495
2006 $-3,577
2005 $628
Boston Scientific Quarterly Net Income
(Millions of US $)
Q4 2018 $386
Q3 2018 $432
Q2 2018 $555
Q1 2018 $298
Q4 2017 $-615
Q3 2017 $283
Q2 2017 $146
Q1 2017 $290
Q4 2016 $124
Q3 2016 $228
Q2 2016 $-207
Q1 2016 $202
Q4 2015 $-142
Q3 2015 $-198
Q2 2015 $102
Q1 2015 $-1
Q4 2014 $-299
Q3 2014 $43
Q2 2014 $4
Q1 2014 $133
Q4 2013 $108
Q3 2013 $-5
Q2 2013 $130
Q1 2013 $-354
Q4 2012 $61
Q3 2012 $-664
Q2 2012 $-3,578
Q1 2012 $113
Q4 2011 $107
Q3 2011 $142
Q2 2011 $146
Q1 2011 $46
Q4 2010 $236
Q3 2010 $190
Q2 2010 $98
Q1 2010 $-1,589
Q4 2009 $-1,076
Q3 2009 $-94
Q2 2009 $158
Q1 2009 $-13
Q4 2008 $-2,382
Q3 2008 $-74
Q2 2008 $98
Q1 2008 $322
Q4 2007 $-458
Q3 2007 $-272
Q2 2007 $115
Q1 2007 $120
Q4 2006 $277
Q3 2006 $76
Q2 2006 $-4,262
Q1 2006 $332
Q4 2005 $334
Q3 2005 $-269
Q2 2005 $205
Q1 2005 $358
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $48.570B $9.823B
Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $130.875B 25.52
Medtronic (MDT) Ireland $112.858B 16.50
Stryker (SYK) United States $67.965B 24.92
Baxter (BAX) United States $38.462B 24.67
Zimmer Biomet Holdings (ZBH) United States $24.795B 15.86
Canopy Growth (CGC) Canada $16.605B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $16.541B 0.00
ResMed (RMD) United States $14.331B 27.18
Aurora Cannabis (ACB) Canada $9.351B 65.93
Bio-Rad Laboratories (BIO) United States $8.746B 50.17
Perrigo (PRGO) Ireland $6.654B 10.79
Hill-Rom Holdings (HRC) United States $6.265B 19.38
Insulet (PODD) United States $4.918B 1648.60
GW Pharmaceuticals (GWPH) United Kingdom $4.886B 0.00
ICU Medical (ICUI) United States $4.648B 28.79
Haemonetics (HAE) United States $4.248B 37.69
Hutchison China MediTech (HCM) China $4.058B 0.00
Agios Pharmaceuticals (AGIO) United States $3.323B 0.00
Neogen (NEOG) United States $2.935B 47.73
NuVasive (NUVA) United States $2.870B 24.93
Quidel (QDEL) United States $2.395B 21.43
National Vision Holdings (EYE) United States $2.233B 43.92
Aphria (APHA) $1.970B 0.00
HEXO (HEXO) $1.493B 0.00
Phibro Animal Health (PAHC) United States $1.350B 19.40
Cardiovascular Systems (CSII) United States $1.210B 868.75
VAREX IMAGING (VREX) United States $1.209B 23.67
AtriCure (ATRC) United States $1.055B 0.00
Lantheus Holdings (LNTH) United States $0.930B 25.13
Omeros (OMER) United States $0.916B 0.00
PetIQ (PETQ) United States $0.851B 24.35
Cerus (CERS) United States $0.808B 0.00
MacroGenics (MGNX) United States $0.796B 0.00
NanoString Technologies (NSTG) United States $0.744B 0.00
TG Therapeutics (TGTX) United States $0.699B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.676B 23.00
Evolus (EOLS) United States $0.665B 0.00
OraSure Technologies (OSUR) United States $0.585B 25.46
Surmodics (SRDX) United States $0.569B 82.72
LeMaitre Vascular (LMAT) United States $0.539B 25.61
Meridian Bioscience (VIVO) United States $0.534B 15.90
Quanterix (QTRX) United States $0.492B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.330B 0.00
Insys Therapeutics (INSY) United States $0.322B 0.00
Utah Medical Products (UTMD) United States $0.321B 20.90
BioLife Solutions (BLFS) United States $0.303B 125.08
Vapotherm (VAPO) United States $0.281B 0.00
Rockwell Medical (RMTI) United States $0.263B 0.00
Cytosorbents (CTSO) United States $0.227B 0.00
Owens & Minor (OMI) United States $0.214B 2.93
Zynex (ZYXI) United States $0.170B 18.21
Chimerix (CMRX) United States $0.136B 0.00
Bovie Medical (APYX) United States $0.132B 0.00
Fonar (FONR) United States $0.123B 6.59
Chembio Diagnostics (CEMI) United States $0.120B 0.00
Surface Oncology (SURF) United States $0.111B 0.00
Female Health (VERU) United States $0.090B 0.00
United-Guardian (UG) United States $0.089B 20.42
InfuSystems Holdings (INFU) United States $0.088B 0.00
Neurotrope (NTRP) United States $0.078B 0.00
Trinity Biotech (TRIB) Ireland $0.069B 20.64
Oramed Pharmaceuticals (ORMP) United States $0.069B 0.00
GUARDION HEALTH (GHSI) United States $0.049B 0.00
ImmuCell (ICCC) United States $0.042B 0.00
Senestech (SNES) United States $0.036B 0.00
Valeritas Holdings (VLRX) United States $0.030B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.023B 0.00
Myomo (MYO) United States $0.021B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.007B 13.00